Aeterna Zentaris Selects Charleston, S.C. as New Location for its North American Business and Global Commercial Operations

Mon, 05/05/2014 - 8:27am

Aeterna Zentaris today announced that it has selected Charleston, South Carolina as its new location for the Company's North American business and global commercial operations. Over the next five years, Aeterna Zentaris is expected to implement a staff to support the areas of commercial operations, business development, regulatory and quality assurance, manufacturing management, clinical and product development, as well as various administrative functions. In conjunction with the company's plans and commitment to this investment, the Coordinating Council for Economic Development of South Carolina has approved job development credits to Aeterna Zentaris.

David Dodd, President and CEO at Aeterna Zentaris commented, "The Charleston, South Carolina area is one of the most thriving and exciting business communities in the United States and we are very much looking forward to becoming part of it. Establishing our North American business and global commercial activities here is part of our strategic plan not only for the launch of MACRILENTM in the United States, as potentially the first FDA approved oral product for use in evaluating growth hormone deficiency in adults, but also for our future commercial opportunities. Furthermore, this marks an important milestone in Aeterna Zentaris' transition from an R&D company into a commercially operating company. As we evaluated our options, we were highly impressed by the commitment to life sciences demonstrated by the leadership of South Carolina and the emergence of Charleston as a collaborative center for research and development in the biopharmaceutical industry. We especially want to thank and acknowledge the leadership within the South Carolina Research Authority, the South Carolina Department of Commerce, the Charleston Regional Development Alliance and the team at the Medical University of South Carolina, all of whom contributed to this significant decision for our corporation. Finally, we wish to thank Governor Nikki Haley, who personally conveyed the state's commitment to assisting companies such as Aeterna Zentaris, in successfully developing the bio-industry throughout South Carolina."

Nikki Haley, Governor of South Carolina stated, "We are excited Aeterna Zentaris chose Charleston to be the home of their new North American business and global commercial operations - further proof that South Carolina is attracting cutting-edge research and development. We celebrate their decision to invest and to create new jobs in the Charleston area."  



Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.